A needleless, remote-controlled device for tissue expansion is awaiting FDA approval.
The billionaire is the first major donor to back the idea of creating an atlas of all human cells.
Biologists are getting closer to figuring out why nature ties knots in some molecules, which could lead to better drug discovery.
Synthetic biologists are developing genetically modified bacteria that you swallow, but no one knows yet how they should be regulated.
The Department of Defense is backing an effort to use machine learning to find clues about tumor biology.
Nonprofits and corporations are in a race to fight dengue and Zika.
The latest gaming craze increases activity levels for players, regardless of their age, sex, or weight.
It might come down to the same network theory that rules computer science and economics.
One in 10 people suffers from chronic kidney disease and could use an engineered alternative to a transplant.
The government’s latest plans to beat cancer range from inspiring to highly questionable.